Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study
Year: 2017
Type: article
Study design: Clinical Trial
Institutions: Saint Louis University, Washington University in St. Louis
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Celgene
Award: G3961717371
OpenAlex ID: W2623834745
